News

Ross Stores, Inc. ROST is currently trading at a discount relative to its industry peers. The stock trades at a forward 12-month price-to-earnings (P/E) ratio of 21.41X, lower than the industry’s

KLA Corporation KLAC is set to report its third-quarter fiscal 2025 results on April 30.For the third quarter of fiscal 2025, KLAC expects revenues of $3 billion, plus/minus $150 million. The Zacks

Byrna Technologies Inc. BYRN has seen a sharp fall in its stock price, declining 39% in three months compared to the broader industry’s 2.7% decline. This aligns with the performance of other

Leading healthcare plan provider Humana Inc. HUM is set to report its first-quarter 2025 results on April 30, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s

UiPath Inc. PATH has seen its stock drop 41% in the past year, underperforming its industry, which has rallied 21% over the same period. However, the stock has rebounded 8% in the last month

Amphenol (APH) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report second-quarter fiscal 2025 results on May 1, before market open.

In the last reported quarter, the company’s earnings

Monolithic Power Systems, Inc. MPWR is set to release first-quarter 2025 results on May 1, after the closing bell. In the last reported quarter, adjusted earnings were $4.09 per share.This Kirkland

On April 24, American Airlines AAL reported narrower-than-expected loss per share for the first quarter of 2025.  However, the loss widened on a year-over-year basis. Revenues surpassed the Zacks

Americans remain uncertain about the economic future, particularly in light of ongoing trade tensions and potential tariff impacts, which have dampened consumer sentiment. Falling consumer sentiment

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering VSE (VSEC), which belongs to the Zacks

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Essential Utilities (WTRG), which

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering SharkNinja, Inc. (SN), which belongs to the

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering UBS (UBS), which belongs to the Zacks Banks -

Adobe ADBE and Autodesk ADSK are well-known creative software providers. Both companies have been leveraging artificial intelligence (AI) to offer software for creators and improve workflow

The first-quarter earnings season for the drug and biotech sector will be in full swing this week, with many large drugmakers like Pfizer PFE, Eli Lilly LLY, Amgen AMGN, Biogen BIIB, and Regeneron

Investors in Northeast Community Bancorp, Inc. NECB need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $15.00 Call had some of

Meta Platforms META is set to report its first-quarter 2025 results on April 30.META expects total revenues between $39.5 billion and $41.8 billion for the first quarter of 2025, indicating 8-15%

Investors in Central Pacific Financial CPF need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $25.00 Call had some of the highest

Esquire Financial Holdings, Inc. (ESQ) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates

Investors might want to bet on Adidas AG (ADDYY), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Investors might want to bet on PAVmed Inc. (PAVM), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of

Supernus Pharmaceuticals (SUPN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is

South Plains Financial (SPFI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates